Gilead's antiviral drug remedesivir being made in India on trial basis

Local drug makers start developing patented drug as govt too wishes to try it on Indians

Inspired by the positive initial responses shown in global studies, India is planning to use a broad spectrum anti-viral drug remedesivir on patients here. A handful of Indian pharma majors have also started working on developing the patented drug that was innovated by US pharma giant Gilead. Moreover, firms like Glenmark have approached the country's drug regulator to do trials on another anti-viral drug favipiravir. 

In fact, India is now working on evaluating about 20 different drugs that can be used as a line of treatment against COVID19. 

Gilead's remedesivir was orginally developed for Ebola and then eventually found to be useful